PDK2 Antibody, mAb, Rabbit
| $210.00 | |
| A04000-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $210.00 | |
| A04000-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to PDK2 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human PDK2 |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||||
|
|||||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of PDK2 expression in (1) SH-SY5Y cell lysate; (2) Mouse heart lysate. »
| Target Background | Kinase that plays a key role in the regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose utilization and increases fat metabolism. Mediates cellular responses to insulin. |
| Synonyms | PDHK2; PDK2; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.